PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement

  1. Isla, D.
  2. Sánchez, A.
  3. Casal, J.
  4. Cobo, M.
  5. Majem, M.
  6. Reguart, N.
  7. Zugazagoitia, J.
  8. Bernabé, R.
Journal:
Journal of Clinical Medicine

ISSN: 2077-0383

Year of publication: 2023

Volume: 12

Issue: 15

Type: Article

DOI: 10.3390/JCM12155063 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals